Gilead Sciences Inc (GILD) Files 10-K for the Fiscal Year Ended on December 31, 2018

Gilead Sciences Inc (NASDAQ:GILD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases. Gilead Sciences Inc has a market cap of $83.69 billion; its shares were traded at around $65.28 with a P/E ratio of 15.69 and P/S ratio of 3.85. The dividend yield of Gilead Sciences Inc stocks is 3.49%. Gilead Sciences Inc had annual average EBITDA growth of 31.10% over the past ten years. GuruFocus rated Gilead Sciences Inc the business predictability rank of 4-star.

For the last quarter Gilead Sciences Inc reported a revenue of $5.8 billion, compared with the revenue of $5.9 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $22.1 billion, a decrease of 15.2% from the previous year. For the last five years Gilead Sciences Inc had an average revenue growth rate of 10.4% a year.

The reported diluted earnings per share was $4.17 for the year, an increase of 18.8% from previous year. Over the last five years Gilead Sciences Inc had an EPS growth rate of 5.2% a year. The Gilead Sciences Inc had a decent operating margin of 37.06%, compared with the operating margin of 54.1% a year before. The 10-year historical median operating margin of Gilead Sciences Inc is 50.37%. The profitability rank of the company is 9 (out of 10).

At the current stock price of $65.28, Gilead Sciences Inc is traded at 21% discount to its historical median P/S valuation band of $82.62. The P/S ratio of the stock is 3.85, while the historical median P/S ratio is 4.87. The intrinsic value of the stock is $118.43 a share, according to GuruFocus DCF Calculator. The stock lost 17.4% during the past 12 months.

Directors and Officers Recent Trades:

Director Gayle E Wilson sold 19,068 shares of GILD stock on 02/19/2019 at the average price of $67.08. The price of the stock has decreased by 2.68% since.

For the complete 20-year historical financial data of GILD, click here.